Caleb Bell
Private Equity Investor chez CTIC Capital LLC
Profil
Caleb B.
Bell was the founder of Bell Biosystems, Inc. (founded in 2009) and Digital Movement, Inc. (founded in 1999), where he held the titles of Director and CEO respectively.
Currently, Dr. Bell is the Managing Director at CTIC Capital LLC (since 2022) and a Venture Partner at Beyond Next Ventures, Inc. (since 2019).
He is also an Advisor at Myoridge KK (since 2018), Metcela, Inc. (since 2019), and GlycoMira Therapeutics, Inc. (since 2022).
Previously, Dr. Bell served as a Director at IVIVA Medical, Inc. (2021), a member of the Institute Board of Directors at California Life Sciences Association (2014-2020), a Director at Elevian, Inc. (2021), a Partner at Prime Movers Lab LLC (2020-2021), a Senior Advisor at Arcline Investment Management LP (2019), and an Advisor at Argonaut Genomics, Inc. (2020-2022).
Dr. Bell obtained a doctorate degree from Stanford University in 2011, an undergraduate degree from The Pennsylvania State University, and an MBA from Stanford Graduate School of Business in 2009.
Postes actifs de Caleb Bell
| Sociétés | Poste | Début |
|---|---|---|
| CTIC Capital LLC | Private Equity Investor | 01/01/2022 |
Beyond Next Ventures, Inc.
 Beyond Next Ventures, Inc. Investment ManagersFinance Beyond Next Ventures, Inc. (Beyond Next Ventures) is an Independent Venture Capital firm founded in 2014. Beyond Next Ventures, Inc. is headquartered in Tokyo. | Private Equity Investor | 01/03/2019 |
GlycoMira Therapeutics, Inc.
 GlycoMira Therapeutics, Inc. BiotechnologyHealth Technology GlycoMira Therapeutics, Inc. is a preclinical-stage biopharmaceutical company based in Salt Lake City, UT. The private company is dedicated to improving the standard of care and outcomes for patients with cancer and other inflammatory diseases. GlycoMira is developing a new class of innate immune system modulators based on polysaccharides that naturally occur within the body. The company's lead drug candidate, GM-1111, has demonstrated potential to address unmet needs in solid tumor treatment and supportive care. The CEO of the company is William P. Tew. | Consultant / Advisor | 01/02/2022 |
Metcela, Inc.
 Metcela, Inc. Miscellaneous Commercial ServicesCommercial Services Metcela, Inc. provides therapies for heart failure treatment. The company was founded by Takahiro Iwamiya and Kenichi Nogami on March 09, 2016 and is headquartered in Kawasaki, Japan. | Consultant / Advisor | 01/06/2019 |
Myoridge KK
 Myoridge KK BiotechnologyHealth Technology Myoridge KK is a company based in Kyoto, Japan that specializes in selling cell products and developing support services for cell culture. The Japanese company also offers development support services for materials, operating methods, and equipment for all stages of the process. The company was founded in 2016 by Naohiro Makita, Shinichi Sueda. | Consultant / Advisor | 01/09/2018 |
Anciens postes connus de Caleb Bell
| Sociétés | Poste | Fin |
|---|---|---|
| Argonaut Genomics, Inc. | Consultant / Advisor | 01/02/2022 |
Iviva Medical, Inc.
 Iviva Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Iviva Medical, Inc. develops autologous tissue to serve kidney diseases. The company was founded by Harald C Ott and is headquartered in Beverly, MA. | Directeur/Membre du Conseil | 01/12/2021 |
Elevian, Inc.
 Elevian, Inc. Pharmaceuticals: MajorHealth Technology Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA. | Directeur/Membre du Conseil | 01/11/2021 |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Directeur/Membre du Conseil | 01/12/2020 |
| ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Caleb Bell
| Stanford University | Doctorate Degree |
| The Pennsylvania State University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Bell Biosystems, Inc.
 Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Health Technology |
Beyond Next Ventures, Inc.
Beyond Next Ventures, Inc. Investment ManagersFinance Beyond Next Ventures, Inc. (Beyond Next Ventures) is an Independent Venture Capital firm founded in 2014. Beyond Next Ventures, Inc. is headquartered in Tokyo. | Finance |
Myoridge KK
Myoridge KK BiotechnologyHealth Technology Myoridge KK is a company based in Kyoto, Japan that specializes in selling cell products and developing support services for cell culture. The Japanese company also offers development support services for materials, operating methods, and equipment for all stages of the process. The company was founded in 2016 by Naohiro Makita, Shinichi Sueda. | Health Technology |
Iviva Medical, Inc.
Iviva Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Iviva Medical, Inc. develops autologous tissue to serve kidney diseases. The company was founded by Harald C Ott and is headquartered in Beverly, MA. | Commercial Services |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Commercial Services |
Prime Movers Lab LLC
 Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | Finance |
Metcela, Inc.
Metcela, Inc. Miscellaneous Commercial ServicesCommercial Services Metcela, Inc. provides therapies for heart failure treatment. The company was founded by Takahiro Iwamiya and Kenichi Nogami on March 09, 2016 and is headquartered in Kawasaki, Japan. | Commercial Services |
Arcline Investment Management LP
 Arcline Investment Management LP Investment ManagersFinance Arcline Investment Management LP (Arcline Investment) is a private equity firm founded in 2018 by Rajeev Joseph Amara. The firm is headquartered in San Francisco, California. | Finance |
GlycoMira Therapeutics, Inc.
GlycoMira Therapeutics, Inc. BiotechnologyHealth Technology GlycoMira Therapeutics, Inc. is a preclinical-stage biopharmaceutical company based in Salt Lake City, UT. The private company is dedicated to improving the standard of care and outcomes for patients with cancer and other inflammatory diseases. GlycoMira is developing a new class of innate immune system modulators based on polysaccharides that naturally occur within the body. The company's lead drug candidate, GM-1111, has demonstrated potential to address unmet needs in solid tumor treatment and supportive care. The CEO of the company is William P. Tew. | Health Technology |
Elevian, Inc.
Elevian, Inc. Pharmaceuticals: MajorHealth Technology Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA. | Health Technology |
| CTIC Capital LLC | |
| Argonaut Genomics, Inc. | |
| Digital Movement, Inc. |